P090 Treatment use among SIMPLIFY trial participants through 24 weeks of follow-up

Alex H. Gifford, K. Odem-Davis,Margaret Kloster, Richard Russell, James K. Young, Brian O’Sullivan, Gregory J. Omlor,Susan L. Millard, J.P. Clancy, G.S. Sawicki,Kristin A. Riekert,Nicole Mayer-Hamblett,David P. Nichols

Journal of Cystic Fibrosis（2023）

引用 0|浏览6

暂无评分

摘要

Objectives: Many people with cystic fibrosis (pwCF) infrequently or no longer use chronic treatments due to improved health on elexacaftor/tezacaftor/ivacaftor (ETI). How often they resume using these treatments after discontinuation, when this occurs, and whether perceived treatment burden correlates with likelihood of resumption are unknown.

查看译文

关键词

simplify trial participants,treatment,weeks

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要